Oestrogen’s Impact on Parkinson’s Dementia

 

Oestrogen’s Impact on Parkinson’s Dementia: Balancing Potential Benefits and Risks

Parkinson’s dementia—a cognitive decline that affects up to 80% of people with Parkinson’s disease (PD)—presents unique challenges. Emerging research suggests oestrogen may influence both motor and cognitive symptoms, but the evidence remains nuanced. Here’s what we know so far:


Potential Cognitive Benefits in PD

  1. Neuroprotection for Dopamine Systems:
    Oestrogen appears to protect dopamine-producing neurons, which degenerate in PD. A 2019 imaging study found that postmenopausal women with longer lifetime oestrogen exposure had healthier dopamine systems and less severe motor symptoms, suggesting a possible indirect benefit for cognitive function7.
  2. Reduced Risk of Parkinson’s Dementia:
    While no studies directly target Parkinson’s dementia, a 2020 meta-analysis linked oestrogen replacement therapy (ERT) to a lower risk of developing Parkinson’s disease (odds ratio 0.47)2. Since dementia often follows motor symptoms, delaying PD onset could theoretically reduce dementia risk.
  3. Improved Non-Motor Symptoms:
    Oestrogen’s effects on mood, sleep, and fatigue—common non-motor issues in PD—might indirectly support cognitive health by improving quality of life7.

Controversies and Risks

  1. Mixed Findings on Dementia Risk:
    Large observational studies report conflicting results. A 2021 BMJ study found no overall increased dementia risk with hormone therapy, but long-term oestrogen-progestogen use was linked to a higher risk of Alzheimer’s disease6. Another 2023 study highlighted a 24% increased dementia risk with oestrogen-progestogen therapy3. These studies focused on general populations, not PD-specific dementia.
  2. Timing and Formulation Matter:
    Animal studies suggest oestrogen’s benefits depend on early intervention and specific formulations (e.g., 17β-estradiol)4. For women with PD, starting ERT soon after menopause might optimize effects, but this remains untested in clinical trials.

Key Takeaways for the Parkinson’s Community

  • No Clear Consensus Yet: While oestrogen shows promise for protecting dopamine neurons, its direct impact on Parkinson’s dementia is understudied.
  • Individualized Decisions: Hormone therapy carries risks (e.g., blood clots, certain cancers)36, so decisions should involve neurologists and consider personal health history.
  • Research Gaps: Rigorous trials are needed to explore whether oestrogen supplementation slows cognitive decline in PD and how timing or formulations affect outcomes.

Bottom Line: Oestrogen’s role in Parkinson’s dementia remains uncertain. While it may offer neuroprotective benefits, current evidence is mixed, and risks must be carefully weighed. Always consult your care team before considering hormonal therapies.

Key References:

  • Liu R, Huang X, Chen H. (2020). Front Neurosci2
  • Jeon BS, et al. (2019). Sci Rep7
  • The BMJ (2023). Menopausal hormone therapy and dementia3
  • JAMA Neurology (2004). Postmenopausal Estrogen Use and PD Risk5

For more personalized guidance, connect with Parkinson’s specialists or advocacy groups like the Parkinson’s Foundation.

Citations:

  1. https://pubmed.ncbi.nlm.nih.gov/10227628/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC7076111/
  3. https://www.bmj.com/content/381/bmj-2022-072770
  4. https://pubmed.ncbi.nlm.nih.gov/22548198/
  5. https://jamanetwork.com/journals/jamaneurology/fullarticle/786007
  6. https://www.bmj.com/content/374/bmj.n2182
  7. https://www.nature.com/articles/s41598-019-47026-6
  8. https://www.sciencedirect.com/science/article/abs/pii/S1353802002000147
  9. https://www.news-medical.net/health/Estrogen-as-a-Treatment-for-Parkinsons-Disease.aspx
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC8118114/
  11. https://www.sciencedirect.com/science/article/pii/S1086580216312335
  12. https://www.neurologysolutions.com/hormone-therapy-for-parkinsons-disease/
  13. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00157/full
  14. https://pubmed.ncbi.nlm.nih.gov/32057896/
  15. https://www.balance-menopause.com/menopause-library/menopause-and-parkinsons-what-you-need-to-know/
  16. https://www.menopause.org.au/hp/information-sheets/oestrogen-and-cognition-in-the-perimenopause-and-menopause

 

Comments

Post a Comment

Popular posts from this blog

Oestrogen and Parkinson’s Disease

Image
  Oestrogen and Parkinson’s Disease Can Oestrogen Supplements Help Women with Parkinson’s Disease? What the Science Says Parkinson’s disease (PD) affects both men and women, but women often notice changes in their symptoms after menopause, when oestrogen levels drop. This has led many to wonder: could oestrogen supplements help women with Parkinson’s manage their symptoms or even slow the disease? Here’s what the latest research tells us—summed up for the Parkinson’s community. The Link Between Oestrogen and Parkinson’s Oestrogen is a hormone best known for its role in women’s health, but it also has important effects on the brain. Scientists have noticed that women are less likely to develop Parkinson’s than men, and that risk rises after menopause. This suggests oestrogen might help protect the brain cells that are lost in Parkinson’s. A large meta-analysis pooling results from many studies found that women who used oestrogen therapy after menopause had ...
Read more

Are you serious - Handing back the Chagos Islands

Image
  UK Handing Back  the  Chagos Islands The Implications of the UK Handing Back the Chagos Islands: National and International Security  Perspectives The recent decision by the UK to cede sovereignty of the Chagos Islands to Mauritius marks a significant geopolitical shift with far-reaching implications for national and international security. This move, driven by a United Nations mandate, has sparked a complex web of reactions and strategic recalibrations, particularly concerning the UK’s security interests and the evolving political alliances in the Indian Ocean region. National Secu...
Read more

Economic Policies: A Tug of War

Image
  Economic Policies: A Tug of War Economic Policies: A Tug of War The UK Labour Party’s economic policies have been a subject of intense debate and scrutiny. Under the leadership of Keir Starmer, Labour has promised to be the champion of “wealth creation” for working people, aiming to boost investment in training, skills, and technology. However, this ambition seems at odds with their stance on taxation. The manifesto includes a tax lock pledge, promising not to raise income tax, national insurance, or VAT. This raises questions about how Labour plans to fund its ambitious economic reforms without increasing revenue. Labour’s economic strategy appears to be a tug of war between progressive ideals and pragmatic governance. On one hand, the party seeks to address income inequality and provide better opportunities for the working class. On the other hand, the commitment to not raising taxes on the majority of the population  limits their ability to genera...
Read more